07:00 , Mar 15, 2010 |  BC Week In Review  |  Clinical News

Acologix preclinical data

In goats with knee cartilage defects, 4 weekly intra-articular injections of AC-100 dose-dependently promoted cartilage repair compared to placebo at 6 months. Furthermore, the new cartilage formed was mature, normal hyaline cartilage as measured by...
08:00 , Nov 17, 2008 |  BC Week In Review  |  Clinical News

Acologix preclinical data

In rat models of CKD, AC-200 significantly reduced serum phosphorus and PTH levels vs. control. Data were presented at the American Society of Nephrology meeting in Philadelphia. Acologix Inc., Hayward, Calif.   Product: Phosphatonin human...
07:00 , Sep 22, 2008 |  BC Week In Review  |  Clinical News

Acologix preclinical data

In 2 studies evaluating goats with cartilage defects, compared with saline, AC-100 showed significant improvements in the amount and quality of repair tissue with a dose-dependent effect (p<0.05). The synthetic peptide derived from the matrix...
08:00 , Dec 17, 2007 |  BC Week In Review  |  Clinical News

Acologix preclinical data

Acologix Inc., Hayward, Calif.   Product: Dentonin ( AC-100)   Indication: Cartilage repair   In 15 goats with knee cartilage defects, 2.5 and 25 mg doses of AC-100 produced better healing than placebo (normalized scores: 0.7, 2.9...
07:00 , Oct 1, 2007 |  BioCentury  |  Finance

IPO queue

IPO queue Company Filed Proposed shares To be raised (A) Price range Shares after Status (B) Pronova (Oslo) 9/26/07 25M NOK650M ($117.6M) NOK23-NOK29 300.8M Mkt Elixir Pharma 9/21/07 TBD Up to $86.3M TBD TBD Ph...
07:00 , Jul 2, 2007 |  BioCentury  |  Finance

IPO queue

IPO queue Company Filed Proposed shares To be raised (A) Price range Shares after Status (B) Map Pharma 6/18/07 TBD Up to $86.3M TBD TBD Ph II compl Zars 6/11/07 TBD Up to $86.3M TBD...
07:00 , Apr 2, 2007 |  BioCentury  |  Finance

IPO queue

IPO queue Company Filed Proposed shares To be raised (A) Price range Shares after Status (B) Amicus (C) 3/30/07 TBD Up to $86.3M TBD TBD Ph II Merrion (NASDAQ & Irish Enterprise Exchange) 3/30/07 TBD...
08:00 , Jan 1, 2007 |  BioCentury  |  Finance

IPO queue

IPO queue IPO queue At least 14 IPOs are pending, five of them added in 4Q06. NASDAQ listing proposed unless otherwise noted. (A) If proposed shares and price range are available, amount to be raised...
07:00 , Sep 11, 2006 |  BC Week In Review  |  Company News

Acologix, University of Maryland deal

The university granted Acologix a license to patents related to heparin-binding epidermal growth factor-like growth factor (HB-EGF) and therapies targeting anti-proliferative factor (APF) to treat interstitial cystitis. Further terms were not disclosed. Acologix Inc., Hayward,...
07:00 , Aug 21, 2006 |  BioCentury  |  Finance

Ebb & Flow

Until last week,Third Point had been waging a quiet war against the board of Nabi (NABI), demanding in two SEC filings in April and June that the company seek a buyer. Last week, the hedge...